Abiopharma

MREO Deadline: MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

Stack Capital Group Inc. Announces Upsize to Its Previously Announced Best Efforts Financing for Up to $30,000,000

General Announcement: Release of Annual Report - UOA Development Bhd

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

ビザ、カントン・ネットワークにプライバシー保護型決済を導入

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN

Director Ellis Stephen A 🟡 adjusted position in 0 shares (2 derivative) of SCHWAB CHARLES CORP (SCHW) at $28.96 Transaction Date: Mar 24, 2026 | Filing ID: 000008

CHISM DANIEL M 🟡 adjusted position in 4.4K shares of TSS, Inc. (TSSI) at $12.40 Transaction Date: Mar 23, 2026 | Filing ID: 002765

Warrants - Listing Confirmation: Product Listings

SURG attributes changed: Attr: Fin_status N -> D;